These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7846895)

  • 21. Metabolic flexibility in the development of insulin resistance and type 2 diabetes: effects of lifestyle.
    Corpeleijn E; Saris WH; Blaak EE
    Obes Rev; 2009 Mar; 10(2):178-93. PubMed ID: 19207879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The deadly quartet--the insulin resistance syndrome.
    Opara JU; Levine JH
    South Med J; 1997 Dec; 90(12):1162-8. PubMed ID: 9404899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hypertension, microalbuminuria and insulin resistance in diabetes mellitus].
    Bretzel RG
    Wien Klin Wochenschr; 1994; 106(24):774-92. PubMed ID: 7846897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.
    de Vries R; Borggreve SE; Dullaart RP
    Clin Lab; 2003; 49(11-12):601-13. PubMed ID: 14651331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus.
    Annuzzi G; De Natale C; Iovine C; Patti L; Di Marino L; Coppola S; Del Prato S; Riccardi G; Rivellese AA
    Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2397-402. PubMed ID: 15458975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The metabolic syndrome: from inherited survival trait to a health care problem.
    Colagiuri S; Brand Miller JC
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():54-60. PubMed ID: 9288547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
    Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
    Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of the Randle-Mechanism in the etiology of diabetes type II.
    Felber JP
    Horm Metab Res Suppl; 1990; 22():11-7. PubMed ID: 2202623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Metabolic aspects of obesity].
    Muntoni S
    Minerva Med; 1975 May; 66(37):1741-7. PubMed ID: 1128820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of type 2 (non-insulin dependent) diabetes and the metabolic syndrome with diet].
    Bruns W
    Z Gesamte Inn Med; 1991 Oct; 46(15):563-7. PubMed ID: 1771927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic syndrome as a cardiovascular risk factor.
    Krone W; Meinertz T
    Herz; 1995 Feb; 20(1):2-4. PubMed ID: 7713474
    [No Abstract]   [Full Text] [Related]  

  • 32. [Fat infusion and carbohydrate metabolism].
    Reinauer H
    Infusionsther Klin Ernahr; 1983 Jun; 10(3):134-41. PubMed ID: 6224746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GPR43: an emerging target for the potential treatment of type 2 diabetes, obesity and insulin resistance.
    Tiwari A
    Curr Opin Investig Drugs; 2010 Apr; 11(4):385-93. PubMed ID: 20336586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The misconstrued metabolic syndrome essential hypertension. Chronology of interdisciplinary change in attitude].
    Rett K; Wicklmayr M; Dietze G; Mehnert H
    Med Klin (Munich); 1991 Feb; 86(2):86-91. PubMed ID: 2030665
    [No Abstract]   [Full Text] [Related]  

  • 35. Role of glucocorticoids and fatty acids in the impairment of lipid metabolism observed in the metabolic syndrome.
    Brindley DN
    Int J Obes Relat Metab Disord; 1995 May; 19 Suppl 1():S69-75. PubMed ID: 7550541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Obesity and insulin resistance syndrome].
    Tokunaga K; Matsuzawa Y
    Nihon Rinsho; 1996 Oct; 54(10):2679-86. PubMed ID: 8914427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Metabolic syndrome and type II diabetes].
    Fessler B
    Med Monatsschr Pharm; 1992 Oct; 15(10):312-3. PubMed ID: 1406442
    [No Abstract]   [Full Text] [Related]  

  • 38. [Insulin resistance and hyperlipoproteinemia].
    Skrha J
    Vnitr Lek; 1995 Feb; 41(2):105-9. PubMed ID: 7725633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Biochemical research on the lipid spectrum in patients with arteriosclerosis, diabetes and obesity].
    Verdonk G; Mortelmans R; Vandevivere D
    Brux Med; 1972 Mar; 52(3):165-6. PubMed ID: 5022749
    [No Abstract]   [Full Text] [Related]  

  • 40. The evolutionary benefit of insulin resistance.
    Soeters MR; Soeters PB
    Clin Nutr; 2012 Dec; 31(6):1002-7. PubMed ID: 22682085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.